Premature Ovarian Failure Treatments

LIPOFEN is indicated as adjunctive therapy to diet: to reduce triglyceride levels in adults with severe hypertriglyceridemia . to reduce elevated low-density lipoprotein cholesterol in adults with primary hyperlipidemia when use of recommended LDL-C lowering therapy is not possible. LIPOFEN is a peroxisome proliferator-activated receptor alpha agonist indicated as an adjunct to diet: to reduce triglyceride levels in adults with severe hypertriglyceridemia . to reduce elevated low-density lipoprotein cholesterol in adults with primary hyperlipidemia when use of recommended LDL-C lowering therapy is not possible Limitations of Use: Markedly elevated levels of serum TG may increase the risk of developing pancreatitis. The effect of fenofibrate therapy on reducing this risk has not been determined . Fenofibrate did not reduce coronary heart disease morbidity and mortality in two large, randomized controlled trials of patients with type 2 diabetes mellitus. Limitations of Use Markedly elevated levels of serum TG may increase the risk of developing pancreatitis. The effect of fenofibrate therapy on reducing this risk has not been determined [see Warnings and Precautions.